Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 571–585 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5120 PLEC Gene Epidermolysis Bullosa Simplex (Ogna Type) NGS Genetic Analysis Test This test identifies pathogenic variants in the PLEC gene associated with Ogna-type epidermolysis bullosa simplex.	Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PLEC gene", "Deletions/Duplications in the PLEC gene"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Informed consent documentation needed"] Indications ["Suspected Ogna-type epidermolysis bullosa simplex", "Family history of PLEC-related epidermolysis bullosa", "Need for genetic counselling and reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 83039-0 ICD-10: Q81.0, Q81.8, Z14.8 Clinical summary This test identifies pathogenic variants in the PLEC gene associated with Ogna-type epidermolysis bullosa simplex.
TEST-5466 PMP22 Gene (HNPP) Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants within the PMP22 gene associated with Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). It analyzes the full coding region,...	Whole Blood (2–3 mL in DNA preservation tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PMP22 gene sequence", "Copy Number Variations (CNVs) in PMP22", "Single Nucleotide Variants (SNVs)", "Small Insertions/Deletions (Indels)"] Parameters [] Preparation ["Completion of clinical history intake", "Mandatory pre-test genetic counseling session"] Indications ["Diagnosis confirmation of HNPP", "Identification of specific PMP22 variants", "Genetic counselling for affected families", "Risk assessment for family members"] Measurement technique Confirm with laboratory Codes LOINC: 81329-1 ICD-10: G60.8 Clinical summary This test identifies pathogenic variants within the PMP22 gene associated with Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). It analyzes the full coding region, exon-intron boundaries, and copy number variations.
TEST-5448 PNKD Gene (Paroxysmal Nonkinesigenic Dyskinesia) Genetic Test This genetic test identifies pathogenic variants within the PNKD gene associated with paroxysmal nonkinesigenic dyskinesia.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PNKD gene", "Copy number variants within the PNKD gene"] Parameters [] Preparation ["Genetic counseling session required before testing", "Full pedigree chart required"] Indications ["Suspected diagnosis of Paroxysmal Nonkinesigenic Dyskinesia", "Family history of PNKD"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: G24.8 Clinical summary This genetic test identifies pathogenic variants within the PNKD gene associated with paroxysmal nonkinesigenic dyskinesia.
TEST-4970 PNPLA1 Gene Sequencing for Autosomal Recessive Congenital Ichthyosis (ARCI) Test This test evaluates the PNPLA1 gene for variants associated with Autosomal Recessive Congenital Ichthyosis (ARCI). It identifies mutations within the gene's coding region.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PNPLA1 gene coding region variants", "Pathogenic mutations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Provide family medical history and pedigree chart"] Indications ["Suspected diagnosis of Autosomal Recessive Congenital Ichthyosis (ARCI)", "Family history of ARCI", "Need for genetic counselling regarding ARCI risk"] Measurement technique Confirm with laboratory Codes LOINC: 81263-5 ICD-10: Q80.8, Q80.9 Clinical summary This test evaluates the PNPLA1 gene for variants associated with Autosomal Recessive Congenital Ichthyosis (ARCI). It identifies mutations within the gene's coding region.
TEST-2628 POLD1 Gene Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy (MDPL) Syndrome Genetic Test This test analyzes the POLD1 gene to identify pathogenic variants associated with Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy (MDPL) syndrome.	Whole Blood (EDTA), Extracted DNA, or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POLD1 gene sequence variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected MDPL syndrome", "Family history of MDPL syndrome", "Guidance for clinical management", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82307-3 ICD-10: E88.1, Q75.8, H90.3 Clinical summary This test analyzes the POLD1 gene to identify pathogenic variants associated with Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy (MDPL) syndrome.
TEST-5615 POLG Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 1, Autosomal Dominant (Genetic Test) This genetic test detects pathogenic variants in the POLG gene associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial deletions type 1 (PEOA1).	Peripheral Whole Blood, DNA FTA Card, or Extracted DNA	21 – 28 Business Days (3 – 4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POLG gene variants (SNVs, indels, CNVs)", "Mitochondrial DNA deletion hotspots"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications"] Indications ["Suspected PEOA1 based on clinical presentation", "Family history of mitochondrial disorders", "Need for definitive molecular diagnosis", "Cascade screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82989-5 ICD-10: H49.4 Clinical summary This genetic test detects pathogenic variants in the POLG gene associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial deletions type 1 (PEOA1).
TEST-4685 POLR3B Gene Leukodystrophy Hypomyelinating Type 8 Genetic Test This genetic test identifies pathogenic variants in the POLR3B gene associated with hypomyelinating leukodystrophy type 8.	Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POLR3B gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Obtain informed consent"] Indications ["Diagnosis of hypomyelinating leukodystrophy type 8", "Confirmation of clinical suspicion"] Measurement technique Confirm with laboratory Codes LOINC: 21643-2 ICD-10: E75.2 Clinical summary This genetic test identifies pathogenic variants in the POLR3B gene associated with hypomyelinating leukodystrophy type 8.
TEST-5267 POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A2, Genetic Test This genetic test identifies mutations in the POMT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type A2 (MDDGA2).	Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the POMT2 gene", "Single nucleotide variants", "Indels", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with clinical symptoms of MDDGA2", "Family members of affected individuals for carrier status determination"] Measurement technique Confirm with laboratory Codes LOINC: 83580-5 ICD-10: G71.2 Clinical summary This genetic test identifies mutations in the POMT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type A2 (MDDGA2).
TEST-5970 POR Gene (Cytochrome P450 Oxidoreductase Deficiency) Adrenal Hyperplasia Genetic Test This genetic test evaluates the POR gene for pathogenic variants associated with cytochrome P450 oxidoreductase deficiency, a form of congenital adrenal hyperplasia.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POR gene", "Presence of mutations causing cytochrome P450 oxidoreductase deficiency"] Parameters [] Preparation ["Prior genetic counselling session required", "Fasting is not required", "A simple blood or DNA sample collection is needed"] Indications ["Diagnosis of congenital adrenal hyperplasia (CAH)", "Evaluation of ambiguous genitalia", "Investigation of cortisol deficiency", "Assessment of skeletal malformations"] Measurement technique Confirm with laboratory Codes LOINC: 101404-8 ICD-10: E25.0, E25.8, Z13.228 Clinical summary This genetic test evaluates the POR gene for pathogenic variants associated with cytochrome P450 oxidoreductase deficiency, a form of congenital adrenal hyperplasia.
TEST-5097 PORCN Gene Focal Dermal Hypoplasia Genetic Test This test evaluates the PORCN gene for mutations associated with Focal Dermal Hypoplasia (Goltz syndrome).	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the PORCN gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [{"name": "Gene Coverage", "reference_range": "Full coding region + splice sites ±10 bp"}, {"name": "Sensitivity", "reference_range": ">99.9% for point mutations & small indels"}] Preparation ["No fasting required", "Pre-test genetic counseling recommended"] Indications ["Documented clinical suspicion of Goltz syndrome", "Family history of Goltz syndrome", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 96507-0 ICD-10: Q87.2 Clinical summary This test evaluates the PORCN gene for mutations associated with Focal Dermal Hypoplasia (Goltz syndrome).
TEST-6113 PPARG Gene Lipodystrophy, Familial Partial, Type 3 Genetic Test This test identifies pathogenic variants in the PPARG gene associated with Familial Partial Lipodystrophy Type 3 (FPLD3).	Whole Blood (EDTA) or DNA FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PPARG gene"] Parameters [] Preparation [] Indications ["Diagnosis of Familial Partial Lipodystrophy Type 3 (FPLD3)", "Assessment of eligibility for metreleptin therapy", "Familial cascade screening for FPLD3"] Measurement technique Confirm with laboratory Codes LOINC: 81315-3 ICD-10: E88.1 Clinical summary This test identifies pathogenic variants in the PPARG gene associated with Familial Partial Lipodystrophy Type 3 (FPLD3).
TEST-6088 PPM1K Gene (Maple Syrup Urine Disease, Mild Variant) Genetic Test This test evaluates the PPM1K gene for mutations associated with the mild variant of Maple Syrup Urine Disease (MSUD). It identifies specific genetic alterations linked to impaired...	Peripheral Whole Blood or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PPM1K gene mutations", "Branched-chain amino acid metabolism pathway"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected mild variant of MSUD", "Family history of MSUD", "Unexplained neurological symptoms", "Need for precise genetic diagnosis for dietary management"] Measurement technique Confirm with laboratory Codes LOINC: 21600-5 ICD-10: E71.0 Clinical summary This test evaluates the PPM1K gene for mutations associated with the mild variant of Maple Syrup Urine Disease (MSUD). It identifies specific genetic alterations linked to impaired branched-chain amino acid metabolism.
TEST-4374 PRICKLE2 Gene Progressive Myoclonic Epilepsy Type 5 Genetic Test This genetic test analyzes the PRICKLE2 gene for pathogenic variants associated with progressive myoclonic epilepsy type 5 (EPM5). It uses Next Generation Sequencing (NGS) to detec...	Whole blood (EDTA tube), extracted DNA, or FTA card (peripheral blood specimen)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRICKLE2 gene", "Single nucleotide variants (SNVs)", "Copy number variations (CNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["Detailed clinical history of progressive myoclonic epilepsy symptoms", "Three-generation pedigree chart", "Genetic counselling is mandatory prior to testing"] Indications ["Suspected diagnosis of progressive myoclonic epilepsy type 5 (EPM5)", "Family history of EPM5", "Need for definitive molecular diagnosis to guide treatment and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 62115-2 ICD-10: G40.309, G40.3 Clinical summary This genetic test analyzes the PRICKLE2 gene for pathogenic variants associated with progressive myoclonic epilepsy type 5 (EPM5). It uses Next Generation Sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-3594 PRKAR1A Gene Sequencing for Primary Pigmented Nodular Adrenocortical Disease Type 1 (Carney Complex) Test This test identifies genetic variants in the PRKAR1A gene associated with Carney complex and primary pigmented nodular adrenocortical disease type 1 (PPNAD1).	Peripheral whole blood (2 × 6 mL EDTA tubes) or FTA card capillary blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRKAR1A gene variants", "Single-nucleotide variants", "Insertions/deletions", "Copy-number variations"] Parameters [] Preparation ["No specific fasting required", "Do not interrupt prescribed therapy without consulting your endocrinologist"] Indications ["Clinical features suggestive of PPNAD or Carney complex", "Family history of endocrine tumours"] Measurement technique Confirm with laboratory Codes LOINC: 90261-5 ICD-10: E24.8, Q85.8 Clinical summary This test identifies genetic variants in the PRKAR1A gene associated with Carney complex and primary pigmented nodular adrenocortical disease type 1 (PPNAD1).
TEST-4197 PRKRA Gene DYT16 Genetic Test This test identifies pathogenic variants in the PRKRA gene associated with DYT16 dystonia-parkinsonism.	Peripheral whole blood, FTA card, or extracted DNA	14–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKRA gene"] Parameters [] Preparation [] Indications ["Diagnosis of DYT16 dystonia-parkinsonism", "Carrier detection", "Informed reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 52042-9 ICD-10: G24.1 Clinical summary This test identifies pathogenic variants in the PRKRA gene associated with DYT16 dystonia-parkinsonism.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.